Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03019367 · ClinicalTrials.gov registry record · NA

Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2

A NA study, sponsored by Sharp HealthCare.

Completed
Registry status
NA
Development phase
1,201
Enrollment target

NCT03019367: Completed NA study, sponsored by Sharp HealthCare.

NCT03019367 is a NA study that has completed, run by Sharp HealthCare. The registered enrollment target is 1,201 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03019367, a NA study, has completed, sponsored by Sharp HealthCare.

COMPLETED
Registry status
NA
Development phase
1,201 participants
Enrollment target

Study Summary

This study is being done to find out whether umbilical cord milking (UCM) is at least as good as or better than delayed cord clamping (DCC) to reduce bleeding in the brain or prevent death in premature newborns. The investigators will study short and long term outcomes of infants delivered before 32 weeks gestation that receive either UCM or DCC. \* The trial was stopped by the DSMB for safety in the small strata. They subsequently allowed for continuation of the trial in infants 29-32+6 wk GA.

Interventions

  • PROCEDURE Umbilical cord milking UCM
  • PROCEDURE Delayed cord clamping DCC

Trial Details

FieldValue
Enrollment Target 1,201 participants
Start Date 2017-06-06
Est. Completion 2022-09-16
Phase NA

Sponsor

Sharp HealthCare

32 total trials

What the Registry Record Tells You About NCT03019367

The ClinicalTrials.gov registry entry for NCT03019367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Umbilical cord milking UCM is the first listed.

NCT03019367 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03019367 about?

NCT03019367 is a clinical study titled "Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2". This study is being done to find out whether umbilical cord milking (UCM) is at least as good as or better than delayed cord clamping (DCC) to reduce bleeding in the brain or prevent death in premature newborns. The investigators will study short and long term outcomes of infants delivered before 32...

What is the current status of trial NCT03019367?

This trial is currently completed. It is a NA study. The enrollment target is 1,201 participants. The study started on 2017-06-06. Estimated completion is 2022-09-16.

What interventions are being tested in trial NCT03019367?

The interventions under investigation include: Umbilical cord milking UCM (PROCEDURE), Delayed cord clamping DCC (PROCEDURE).

Who is sponsoring clinical trial NCT03019367?

This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.